Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01600209 · ClinicalTrials.gov registry record
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
A clinical trial, sponsored by Exact Sciences Corporation.
- Completed
- Registry status
- 674
- Enrollment target
NCT01600209: Completed study, sponsored by Exact Sciences Corporation.
NCT01600209 is a clinical trial that has completed, run by Exact Sciences Corporation. The registered enrollment target is 674 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01600209 has completed, sponsored by Exact Sciences Corporation.
- COMPLETED
- Registry status
- 674 participants
- Enrollment target
Study Summary
The objective of this study is to confirm the sensitivity and specificity of a stool DNA test for detection of colorectal cancer and pre-cancer.
Primary Outcome
The primary endpoints are point estimates of the sensitivity of the diagnostic tests for detection of colorectal neoplasms.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 674 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-09 |
What the finished NCT01600209 record still lists
NCT01600209 is an observational study that tracks outcomes without assigning an intervention. The registered 674 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01600209 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01600209 about?
NCT01600209 is a clinical study titled "Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing". The objective of this study is to confirm the sensitivity and specificity of a stool DNA test for detection of colorectal cancer and pre-cancer.
What is the current status of trial NCT01600209?
This trial is currently completed. The enrollment target is 674 participants. The study started on 2011-10. Estimated completion is 2012-09.
Who is sponsoring clinical trial NCT01600209?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06335381 · 674 participants · NA
MOMs Chat and Care Study
- NCT06757634 · 674 participants · Phase 3
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
- NCT04788277 · 675 participants
Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)
- NCT05356234 · 675 participants · NA
Ignite Study of the Jewish Family and Children's Service of the Suncoast, Inc.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia